Akhil Santhosh

Olaparib monotherapy in advanced TNBC patients

Akhil Santhosh, Medical Oncologist at AIIMS New Delhi, shared an article by Alfonso Cortés on X:

“Olaparib monotherapy in advanced TNBC patients with homologous recombination deficiency and without germline mutations in BRCA1/2: the NOBROLA phase 2 study –

  • 6 of 114 pts eligible
  • 50% ORR, CBR
  • further studies needed.”

Olaparib monotherapy in advanced triple-negative breast cancer patients with homologous recombination deficiency and without germline mutations in BRCA1/2: The NOBROLA phase 2 study.

Authors: Alfonso Cortés, et al.

Olaparib monotherapy in advanced TNBC patients

Akhil Santhosh Alfonso Cortés cancer MedOnc NOBROLA olaparib Olaparib monotherapy OncoDaily Oncology RadOnc TNBC